Fundraising Fox

Helocyte

New York, US · Founded 2015 · Delaware corporation

Helocyte is a biotechnology company developing cell-based therapies and life sciences programs. The company focuses on advancing breakthrough treatments within the biotech and life sciences sector.

Founders & leadership

EC
Elizabeth Clark MooreExecutive
DJ
David J. HorinExecutive
FT
Frank TaffyCo-Founder and Board Member

Board

LA
Lindsay A. RosenwaldExecutive Chairman of the Board of Directors
MS
Michael S. WeissBoard director
KW
Kenneth W. CappellBoard director

Reported raises · per SEC filings

Form D private placements

$4M disclosed across 1 round · 2016

$4MraisedNov 2016 · 61 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kenneth W. CappellDirector
  • Elizabeth Clark MooreExecutive Officer
  • David J. HorinExecutive Officer
  • Lindsay A. RosenwaldDirector
  • Michael S. WeissDirector
  • Frank TaffyExecutive Officer, Director
Offering amount
$5M
Amount sold
$4M
Sales commissions
$399.8K
Placement agents
Aegis Capital Corp.
First sale
Oct 2016
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 3

by search overlap

Companies competing with Helocyte for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Helocyte do?
Helocyte is a biotechnology company developing cell-based therapies and life sciences programs. The company focuses on advancing breakthrough treatments within the biotech and life sciences sector.
How much funding has Helocyte raised?
Helocyte has disclosed $4M raised across 1 round.
Where is Helocyte headquartered?
Helocyte is headquartered in New York, US.